The Longitudinal Assessment of Prenatal Cannabis Use on Neonatal Outcomes

Overview

Journal J Perinatol

Specialty Gynecology & Obstetrics

Date 2024 Jun 18

PMID 38890400

Authors

Leah L Habersham

Yasmin L Hurd

Yoko Nomura

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the association between prenatal cannabis use and perinatal outcomes using longitudinal data from pregnant individuals.

Study Design: This secondary-data analysis study utilized data collected from 894 pregnant individuals followed in the Stress in Pregnancy longitudinal study, conducted between 2009 and 2013. The status of cannabis use was ascertained through interviews and electronic medical record reviews to evaluate the effect of cannabis use on perinatal outcomes (NICU admission, preterm delivery, low birth weight, fetal death).

Results: Among participants analyzed, 13.1% used cannabis, who were generally younger (25.9 vs 27.9 years). There was a sevenfold increased risk of fetal death (OR 7.30) among cannabis users relative to non-users. Elevated risk persisted after adjustments of potential confounders (aOR 6.31). Adjusted models also suggested increased low birth weight risk (aOR 1.67).

Conclusion: This study highlights an association between prenatal cannabis use and elevated risks for fetal death and low birth weight.

References

Hayer S, Mandelbaum A, Watch L, Ryan K, Hedges M, Manuzak J . Cannabis and Pregnancy: A Review. Obstet Gynecol Surv. 2023; 78(7):411-428. PMC: 10372687. DOI: 10.1097/OGX.0000000000001159. View

Almada M, Amaral C, Diniz-da-Costa M, Correia-da-Silva G, Teixeira N, Fonseca B . The endocannabinoid anandamide impairs in vitro decidualization of human cells. Reproduction. 2016; 152(4):351-61. DOI: 10.1530/REP-16-0364. View

Maia J, Midao L, Cunha S, Almada M, Fonseca B, Braga J . Effects of cannabis tetrahydrocannabinol on endocannabinoid homeostasis in human placenta. Arch Toxicol. 2019; 93(3):649-658. DOI: 10.1007/s00204-019-02389-7. View

Gauthier T, Guidot D, Kelleman M, McCracken C, Brown L . Maternal Alcohol Use During Pregnancy and Associated Morbidities in Very Low Birth Weight Newborns. Am J Med Sci. 2016; 352(4):368-375. PMC: 5098418. DOI: 10.1016/j.amjms.2016.06.019. View

Harlow A, Wesselink A, Hatch E, Rothman K, Wise L . Male Preconception Marijuana Use and Spontaneous Abortion: A Prospective Cohort Study. Epidemiology. 2020; 32(2):239-247. PMC: 7855868. DOI: 10.1097/EDE.0000000000001303. View

Martinez-Pena A, Perono G, Gritis S, Sharma R, Selvakumar S, Walker O . The Impact of Early Life Exposure to Cannabis: The Role of the Endocannabinoid System. Int J Mol Sci. 2021; 22(16). PMC: 8395329. DOI: 10.3390/ijms22168576. View

Conner S, Bedell V, Lipsey K, Macones G, Cahill A, Tuuli M . Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis. Obstet Gynecol. 2016; 128(4):713-723. DOI: 10.1097/AOG.0000000000001649. View

Warshak C, Regan J, Moore B, Magner K, Kritzer S, Van Hook J . Association between marijuana use and adverse obstetrical and neonatal outcomes. J Perinatol. 2015; 35(12):991-5. DOI: 10.1038/jp.2015.120. View

Varner M, Silver R, Rowland Hogue C, Willinger M, Parker C, Thorsten V . Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet Gynecol. 2014; 123(1):113-125. PMC: 3931517. DOI: 10.1097/AOG.0000000000000052. View

10.

Baia I, Domingues R . The Effects of Cannabis Use during Pregnancy on Low Birth Weight and Preterm Birth: A Systematic Review and Meta-analysis. Am J Perinatol. 2022; 41(1):17-30. DOI: 10.1055/a-1911-3326. View

11.

Lo J, Shaw B, Robalino S, Ayers C, Durbin S, Rushkin M . Cannabis Use in Pregnancy and Neonatal Outcomes: A Systematic Review and Meta-Analysis. Cannabis Cannabinoid Res. 2023; 9(2):470-485. PMC: 11262585. DOI: 10.1089/can.2022.0262. View

12.

Prewitt K, Hayer S, Garg B, Benson A, Hedges M, Caughey A . Impact of Prenatal Cannabis Use Disorder on Perinatal Outcomes. J Addict Med. 2023; 17(3):e192-e198. PMC: 10248186. DOI: 10.1097/ADM.0000000000001123. View

13.

Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A . Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 2000; 355(9212):1326-9. DOI: 10.1016/S0140-6736(00)02115-2. View

14.

Marchand G, Masoud A, Govindan M, Ware K, King A, Ruther S . Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(1):e2145653. PMC: 8796018. DOI: 10.1001/jamanetworkopen.2021.45653. View

15.

Gauthier T, Brown L . In utero alcohol effects on foetal, neonatal and childhood lung disease. Paediatr Respir Rev. 2016; 21:34-37. PMC: 5303127. DOI: 10.1016/j.prrv.2016.08.006. View

16.

Finik J, Nomura Y . Cohort Profile: Stress in Pregnancy (SIP) Study. Int J Epidemiol. 2017; 46(5):1388-1388k. PMC: 5837345. DOI: 10.1093/ije/dyw264. View

17.

Odom G, Cottler L, Striley C, Lopez-Quintero C . Perceived Risk of Weekly Cannabis Use, Past 30-Day Cannabis Use, and Frequency of Cannabis Use Among Pregnant Women in the United States. Int J Womens Health. 2020; 12:1075-1088. PMC: 7678496. DOI: 10.2147/IJWH.S266540. View

18.

Metz T, Allshouse A, Hogue C, Goldenberg R, Dudley D, Varner M . Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol. 2017; 217(4):478.e1-478.e8. PMC: 5614818. DOI: 10.1016/j.ajog.2017.05.050. View

19.

Wang H, Guo Y, Wang D, Kingsley P, Marnett L, Das S . Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat Med. 2004; 10(10):1074-80. DOI: 10.1038/nm1104. View

20.

Popova S, Dozet D, OHanlon G, Temple V, Rehm J . Maternal alcohol use, adverse neonatal outcomes and pregnancy complications in British Columbia, Canada: a population-based study. BMC Pregnancy Childbirth. 2021; 21(1):74. PMC: 7821646. DOI: 10.1186/s12884-021-03545-7. View